Vanguard Group Inc Aziyo Biologics, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Aziyo Biologics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,180,505 shares of AZYO stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,180,505

Previous 988,605 19.41%

Holding current value

$1.71 Million

Previous $1.43 Million 19.4%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	N/A	191,900 Added 19.41%	1,180,505 $1.71 Million
Q1 2025 May 09, 2025	BUY	N/A	55,870 Added 5.99%	988,605 $1.43 Million
Q4 2024 Feb 11, 2025	BUY	N/A	433,690 Added 86.9%	932,735 $1.35 Million
Q3 2024 Nov 13, 2024	BUY	N/A	13,539 Added 2.79%	499,045 $723,000
Q2 2024 Aug 13, 2024	BUY	N/A	69,796 Added 16.79%	485,506 $703,000
Q1 2024 May 10, 2024	BUY	N/A	120,526 Added 40.83%	415,710 $602,000
Q4 2023 Feb 14, 2024	BUY	$1.14 - $1.45 $47,663 - $60,624	41,810 Added 16.5%	295,184 $428,000
Q3 2023 Nov 14, 2023	SELL	$1.13 - $2.52 $1,675 - $3,737	-1,483 Reduced 0.58%	253,374 $362,000
Q2 2023 Aug 14, 2023	BUY	$1.41 - $2.79 $8,974 - $17,758	6,365 Added 2.56%	254,857 $601,000
Q1 2023 May 15, 2023	BUY	$1.19 - $4.96 $41,683 - $173,738	35,028 Added 16.41%	248,492 $375,000
Q4 2022 Feb 10, 2023	BUY	$3.48 - $8.94 $479,892 - $1.23 Million	137,900 Added 182.49%	213,464 $907,000
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.41 $114,965 - $148,155	19,994 Added 35.98%	75,564 $534,000
Q3 2021 Nov 12, 2021	BUY	$6.75 - $9.52 $2,085 - $2,941	309 Added 0.56%	55,570 $386,000
Q2 2021 Aug 13, 2021	BUY	$9.51 - $13.97 $525,532 - $771,996	55,261 New	55,261 $531,000

Others Institutions Holding AZYO

# of Institutions

Shares Held

17.3M

Call Options Held

Put Options Held

View Full List

About AZIYO BIOLOGICS, INC.

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

More about AZYO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Aziyo Biologics, Inc. Transaction History